{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:19:37Z","timestamp":1772497177654,"version":"3.50.1"},"reference-count":23,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To determine the safety and efficacy of anabolic therapy to prevent or reverse wasting and malnutrition in human immunodeficiency virus (HIV)-infected pediatric patients. The anabolic steroid, oxandrolone, was evaluated because of its safe and effective use in other pediatric conditions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Nine HIV-positive children who were malnourished or at risk for malnutrition (4 females, 5 males; 4\u201314 years of age) took oxandrolone for 3 months (.1 mg\/kg\/day orally). Quantitative HIV ribonucleic acid polymerase chain reaction and CD4+ T-cell levels, complete blood cell count (CBC) and chemistry profile, endocrinologic studies, resting energy expenditure, respiratory quotient, nutritional measures, body composition assessment with quantitative computed tomography, and skinfold body composition measurements were determined before treatment, during treatment (3 months), and for 3 months after treatment. Statistical analyses were completed using the Friedman two-way analysis of variance and Spearman correlation tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>No adverse clinical or laboratory events or changes in Tanner staging or virilization occurred. Quantitative HIV ribonucleic acid polymerase chain reaction and CD4+ T-cell levels did not change significantly. Insulin-like growth factor 1 increased, suggesting an anabolic effect of treatment. The rate of weight gain increased during treatment and was maintained after treatment. Linear growth continued and was maintained throughout treatment, whereas bone age did not increase significantly. Anthropometric assessments indicated an increase in muscle mass and a decrease in fat while patients were on treatment, and a mild decrease of muscle and increased fat posttreatment. Likewise, computed tomography scan results demonstrated similar changes in muscle mass. Resting energy expenditure and respiratory quotient remained stable throughout treatment and follow-up. No significant changes were seen in the quality of life questionnaire.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions.<\/jats:title><jats:p>Treatment with oxandrolone for 3 months in HIV-infected children was well-tolerated, safe, and associated with markers of anabolism. The latter effect was maintained partially for 3 months after discontinuation of a 3-month course of therapy. Additional studies are needed to assess the potential benefits and risks of a longer course of therapy or a higher dose of oxandrolone in HIV-infected children.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.104.6.e73","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:45:45Z","timestamp":1092440745000},"page":"e73-e73","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of the Effects of Oxandrolone on Malnourished HIV-Positive Pediatric Patients"],"prefix":"10.1542","volume":"104","author":[{"given":"Sarah","family":"Fox-Wheeler","sequence":"first","affiliation":[{"name":"From the Divisions of Clinical Immunology and Allergy,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Heller","sequence":"additional","affiliation":[{"name":"From the Divisions of Clinical Immunology and Allergy,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathleen M.","family":"Salata","sequence":"additional","affiliation":[{"name":"From the Divisions of Clinical Immunology and Allergy,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Endocrinology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Louisa","family":"Loro","sequence":"additional","affiliation":[{"name":"Radiology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincente","family":"Gilsanz","sequence":"additional","affiliation":[{"name":"Radiology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Haight","sequence":"additional","affiliation":[{"name":"Gastroenterology, Children's Hospital Los Angeles, Los Angeles, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwenn C.","family":"Umman","sequence":"additional","affiliation":[{"name":"Vital Research, Los Angeles, California; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman","family":"Barton","sequence":"additional","affiliation":[{"name":"Bio-Technology General Corporation, Iselin, New Jersey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Church","sequence":"additional","affiliation":[{"name":"From the Divisions of Clinical Immunology and Allergy,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[1999,12,1]]},"reference":[{"key":"2021121003115397500_B1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00005176-199405000-00003","article-title":"Nutritional support in children with HIV: some answers, many questions.","volume":"18","author":"Simpser","year":"1994","journal-title":"J. Pediatr Gastroenterol Nutr"},{"key":"2021121003115397500_B2","first-page":"1130","article-title":"Relationships among nutritional status, disease progression and survival in HIV infection.","volume":"6","author":"Guenter","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2021121003115397500_B3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/ajcn\/57.4.588","article-title":"Growth and body composition in children with human immunodeficiency virus-1 infection.","volume":"57","author":"Miller","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"2021121003115397500_B4"},{"key":"2021121003115397500_B5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0140-6736(92)91592-V","article-title":"Prognostic factors and survival in children with perinatal HIV-1 infection: the Italian register for HIV infections in children.","volume":"339","author":"Tovo","year":"1992","journal-title":"Lancet"},{"key":"2021121003115397500_B6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-3476(05)80694-8","article-title":"Growth failure as a prognostic indicator for progression to acquired immunodeficiency syndrome in children with hemophilia.","volume":"117","author":"Brettler","year":"1990","journal-title":"J Pediatr"},{"key":"2021121003115397500_B7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM198401123100202","article-title":"Acquired immunodeficiency syndrome in infants.","volume":"310","author":"Scott","year":"1984","journal-title":"N Engl J Med"},{"key":"2021121003115397500_B8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-121-6-199409150-00001","article-title":"Megestrol acetate in patients with AIDS-related cachexia.","volume":"121","author":"Von Roenn","year":"1994","journal-title":"Ann Intern Med"},{"key":"2021121003115397500_B9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-121-6-199409150-00002","article-title":"Megestrol acetate in patients with AIDS and cachexia.","volume":"121","author":"Oster","year":"1994","journal-title":"Ann Intern Med"},{"key":"2021121003115397500_B10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00006454-199408000-00021","article-title":"Megestrol acetate for treatment of anorexia associated with human immunodeficiency virus infection in children.","volume":"13","author":"Brady","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"2021121003115397500_B11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1542\/peds.96.4.696","article-title":"Gastrostomy tube supplementation for HIV-infected children.","volume":"96","author":"Miller","year":"1995","journal-title":"Pediatrics"},{"key":"2021121003115397500_B12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00005176-199405000-00004","article-title":"Effect of enteral tube feeding on growth of children with symptomatic human immunodeficiency virus infection.","volume":"18","author":"Henderson","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021121003115397500_B13"},{"key":"2021121003115397500_B14"},{"key":"2021121003115397500_B15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00007611-199308000-00003","article-title":"Effect of anabolic steroids on HIV-related wasting myopathy.","volume":"86","author":"Berger","year":"1993","journal-title":"South Med J"},{"key":"2021121003115397500_B16","first-page":"1","article-title":"Oxandrolone therapy: 25 years experience.","volume":"7","author":"Blizzard","year":"1991","journal-title":"Growth Genet Horm"},{"key":"2021121003115397500_B17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-3476(05)82540-5","article-title":"Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner Syndrome.","volume":"1","author":"Rosenfeld","year":"1992","journal-title":"J Pediatr"},{"key":"2021121003115397500_B18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1651-2227.1990.tb11555.x","article-title":"Effect of oxandrolone on growth and final height in Turner's Syndrome.","volume":"79","author":"Naeraa","year":"1990","journal-title":"Acta Paediatr Scand"},{"key":"2021121003115397500_B19","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ajcn\/36.4.680","article-title":"Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area.","volume":"36","author":"Heymsfield","year":"1982","journal-title":"Am J Clin Nutr"},{"key":"2021121003115397500_B20","first-page":"183","article-title":"Oxandrolone induces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty.","volume":"14","author":"Stanhope","year":"1987","journal-title":"Pediatrician"},{"key":"2021121003115397500_B21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiology.190.3.8115609","article-title":"Gender differences in vertebral body sizes in children and adolescents.","volume":"190","author":"Gilsanz","year":"1994","journal-title":"Radiology"},{"key":"2021121003115397500_B22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1148\/radiology.140.3.7280252","article-title":"Low-dose CT scanning for quantitative spinal mineral analysis.","volume":"140","author":"Cann","year":"1981","journal-title":"Radiology"},{"key":"2021121003115397500_B23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/adc.66.7.841","article-title":"Treatment of constitutional growth delay in prepubertal boys with a prolonged course of low dose oxandrolone.","volume":"66","author":"Papadimitriou","year":"1991","journal-title":"Arch Dis Child"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/104\/6\/e73\/887617\/pe1299000i1p.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/104\/6\/e73\/887617\/pe1299000i1p.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:32:57Z","timestamp":1734507177000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/104\/6\/e73\/62753\/Evaluation-of-the-Effects-of-Oxandrolone-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12,1]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,12,1]]},"published-print":{"date-parts":[[1999,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.104.6.e73","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12,1]]}}}